As the treatment landscape for ALK-positive metastatic non-small cell lung cancer continues to take shape, extended analyses of clinical trial data may offer additional clinical insight on the utility of approved therapies.

, will share a case study in ALK-positive non-small cell lung cancer and discuss recent study findings for an available treatment option. Additionally, they will take questions and share clinical perspective through a live question and answer session.

To obtain clinical perspective and learn about how these results may impact your patients and your practice, watch the live broadcast on 

Wednesday, 5/26 at 6:00pm ET or 8:00pm ET; or on Wednesday, 6/16 at 12:00pm ET or 3:00pm ET

https://studio.mjhassoc.com/reach/takedaoncbroadcast

News

® News page includes the latest in clinical oncology news, including breaking regulatory decisions, clinical trial findings, pivotal and practice-changing data published in academic peer-reviewed journals, and more across solid and hematologic malignancies. Regulatory news includes new drug approvals by the FDA and European Union, priority review and breakthrough therapy designations, and orphan drug and fast track statuses. 

Lung Cancer

JAN-22-OSD1275 - /clinical/lung-cancer

The OncLive Lung Cancer condition center page is a comprehensive resource for clinical news and expert insights on non–small cell lung cancer, small cell lung cancer, mesothelioma, and more. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in lung cancer.

Upcoming Live Broadcast to Feature Recent Data and Case Study in ALK+ Metastatic NSCLC